> Details

Marangi, Giuseppe; Ricciardi, Stefania; Orteschi, Daniela; Lattante, Serena; Murdolo, Marina; Dallapiccola, Bruno; Biscione, Chiara; Lecce, Rosetta; Chiurazzi, Pietro; Romano, Corrado; Greco, Donatella; Pettinato, Rosa; Sorge, Giovanni; Pantaleoni, Chiara; Alfei, Enrico; Toldo, Irene; Magnani, Cinzia; Bonanni, Paolo; Martinez, Federica; Serra, Gigliola; Battaglia, Domenica; Lettori, Donatella; Vasco, Gessica; Baroncini, Anna; [...]

The Pitt‐Hopkins syndrome: Report of 16 new patients and clinical diagnostic criteria

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: The Pitt‐Hopkins syndrome: Report of 16 new patients and clinical diagnostic criteria
  • Contributor: Marangi, Giuseppe; Ricciardi, Stefania; Orteschi, Daniela; Lattante, Serena; Murdolo, Marina; Dallapiccola, Bruno; Biscione, Chiara; Lecce, Rosetta; Chiurazzi, Pietro; Romano, Corrado; Greco, Donatella; Pettinato, Rosa; Sorge, Giovanni; Pantaleoni, Chiara; Alfei, Enrico; Toldo, Irene; Magnani, Cinzia; Bonanni, Paolo; Martinez, Federica; Serra, Gigliola; Battaglia, Domenica; Lettori, Donatella; Vasco, Gessica; Baroncini, Anna; [...]
  • imprint: Wiley, 2011
  • Published in: American Journal of Medical Genetics Part A
  • Language: English
  • DOI: 10.1002/ajmg.a.34070
  • ISSN: 1552-4825; 1552-4833
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title><jats:p>Pitt‐Hopkins syndrome (PTHS) is characterized by severe intellectual disability, typical facial gestalt and additional features, such as breathing anomalies. Following the discovery of the causative haploinsufficiency of transcription factor 4 (<jats:italic>TCF4</jats:italic>), about 60 patients have been reported. We looked for <jats:italic>TCF4</jats:italic> mutations in 63 patients with a suspected PTHS. Haploinsufficiency of <jats:italic>TCF4</jats:italic> was identified in 14 patients, as a consequence of large 18q21.2 chromosome deletions involving <jats:italic>TCF4</jats:italic> (2 patients), gene mutations (11 patients) and a t(14q;18q) balanced translocation disrupting <jats:italic>TCF4</jats:italic> (one patient). By evaluating the clinical features of these patients, along with literature data, we noticed that, in addition to the typical facial gestalt, the PTHS phenotype results from the various combinations of the following characteristics: intellectual disability with severe speech impairment, normal growth parameters at birth, postnatal microcephaly, breathing anomalies, motor incoordination, ocular anomalies, constipation, seizures, typical behavior and subtle brain abnormalities. Although PTHS is currently considered to be involved in differential diagnosis with Angelman and Rett syndromes, we found that combining the facial characteristics with a detailed analysis of both the physical and the neurological phenotype, made molecular testing for PTHS the first choice. Based on striking clinical criteria, a diagnosis of PTHS was made clinically in two patients who had normal <jats:italic>TCF4</jats:italic>. This report deals with the first series of PTHS patients of Italian origin. © 2011 Wiley‐Liss, Inc.</jats:p>